SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended		0 Months Ended	3 Months Ended			6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		0 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Apr. 26, 2013 Actient	Jun. 30, 2013 Actient	Jun. 30, 2013 Net U.S. revenues	Jun. 30, 2012 Net U.S. revenues	Jun. 30, 2013 Net U.S. revenues	Jun. 30, 2012 Net U.S. revenues	Jun. 30, 2013 Testim	Jun. 30, 2012 Testim	Jun. 30, 2013 Testim	Jun. 30, 2012 Testim	Jun. 30, 2013 Testim Net U.S. revenues	Jun. 30, 2012 Testim Net U.S. revenues	Jun. 30, 2013 Testim Net U.S. revenues	Jun. 30, 2012 Testim Net U.S. revenues	Jun. 30, 2013 Testim International revenues	Jun. 30, 2012 Testim International revenues	Jun. 30, 2013 Testim International revenues	Jun. 30, 2012 Testim International revenues	Jun. 30, 2013 XIAFLEX	Jun. 30, 2012 XIAFLEX	Jun. 30, 2013 XIAFLEX	Jun. 30, 2012 XIAFLEX	Jun. 30, 2013 XIAFLEX Net U.S. revenues	Jun. 30, 2012 XIAFLEX Net U.S. revenues	Jun. 30, 2013 XIAFLEX Net U.S. revenues	Jun. 30, 2012 XIAFLEX Net U.S. revenues	Jun. 30, 2013 XIAFLEX International revenues	Jun. 30, 2012 XIAFLEX International revenues	Jun. 30, 2013 XIAFLEX International revenues	Jun. 30, 2012 XIAFLEX International revenues	Jun. 30, 2013 TESTOPEL Net U.S. revenues	Jun. 30, 2012 TESTOPEL Net U.S. revenues	Jun. 30, 2013 TESTOPEL Net U.S. revenues	Jun. 30, 2012 TESTOPEL Net U.S. revenues	Jun. 30, 2013 Edex Net U.S. revenues	Jun. 30, 2012 Edex Net U.S. revenues	Jun. 30, 2013 Edex Net U.S. revenues	Jun. 30, 2012 Edex Net U.S. revenues	Jun. 30, 2013 Other products Net U.S. revenues	Jun. 30, 2012 Other products Net U.S. revenues	Jun. 30, 2013 Other products Net U.S. revenues	Jun. 30, 2012 Other products Net U.S. revenues	Apr. 26, 2013 Urology Actient item	Apr. 26, 2013 Respiratory Actient item
Revenue Recognition
Total net revenues	$ 100,519	$ 78,171	$ 166,691	$ 151,778			$ 27,257	$ 0	$ 27,257	$ 0	$ 54,394	$ 63,724	$ 99,847	$ 122,414	$ 53,185	$ 62,456	$ 98,465	$ 120,363	$ 1,209	$ 1,268	$ 1,382	$ 2,051	$ 18,868	$ 14,447	$ 39,587	$ 29,364	$ 14,952	$ 11,900	$ 26,919	$ 24,491	$ 3,916	$ 2,547	$ 12,668	$ 4,873	$ 14,382	$ 0	$ 14,382	$ 0	$ 5,032	$ 0	$ 5,032	$ 0	$ 7,843	$ 0	$ 7,843	$ 0
Acquisition of Actient
Number of marketed products																																															4	2
Warrants issued (in shares)					1,250,000	1,250,000
Number of warrants sold in connection with the issuance of convertible debt			14,481,950